Companies: 10,795·Total market cap: $144.5T

Ceapro Inc.

Ceapro Inc.

CRPOFOTCHealthcare

$0.17

$-0.03(-13.04%)

Market Cap$13309844

P/E Ratio—

52W High$0.399

52W Low$0.115

Avg Volume557

Open$0.17

Beta1.38

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Ceapro Inc.（CRPOF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CRPOF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.08Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$8.9MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding78.3MShares outstanding history

Next EarningsTBAEarnings history

探索 Ceapro Inc. 数据

分析师预测—

股息不分红

营收$9.6M-48.87%

盈利EPS $-0.06-206.74%

财务快照

FY 2023Revenue$9.6M▼ 48.87% YoY

202120222023

FY 2023Net Income-$4.7M▼ 207.09% YoY

202120222023

FY 2023EPS$-0.06▼ 206.74% YoY

202120222023

TTM:Revenue: $8.9MNet Income: -$6.2MEPS: $-0.08View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$0.17-13.04%$13.3M #2

Abingdon Health Plc

$0.17+0.00%$32.2M #3

American Hemp Ventures, Inc.

$0.98+0.00%$16.5M #4

Eiger BioPharmaceuticals, Inc.

$8.50+6.25%$12.6M #5

Living Cell Technologies Limited

$0.03+24.39%$1.1M #6

Noxopharm Limited

$0.05+0.00%$14.8M

股票表现

1D-96.26%

1W-96.35%

1M+0.00%

3M-2.86%

YTD+7.05%

1Y-51.70%

5Y-69.64%

关于 Ceapro Inc.

CEOGilles R. Gagnon

IPO DateJan 8, 2021

Employees—

CountryCA

Websiteceapro.com

Ceapro Inc. Operating as a biotechnology enterprise, Ceapro Inc. is dedicated to pioneering and bringing to market health and wellness offerings, alongside their underlying technologies, which are all predicated …

Biotechnology HealthcareOTCCA

关于股票概览与关键数据

Ceapro Inc.（CRPOF）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 8, 2021 在 OTC 上市。截至最近交易日，CRPOF 股价为 $0.17，市值约为 $13.3M。过去12个月累计回报 -51.70%，年初至今回报 +7.05%。

2023 财年 Ceapro Inc. 营收 $9.6M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Ceapro Inc.（CRPOF）股价为 $0.17，在 OTC 上市，52周区间为 $0.12 – $0.40。

CRPOF 最新股价CRPOF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议